Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man
- PMID: 2897009
- DOI: 10.1016/s0140-6736(88)92012-0
Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man
Abstract
The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on bone-marrow and peripheral-blood progenitor cells was investigated in a three-phase study in 13 patients with sarcoma. In the first phase patients were given GM-CSF alone. In phase II, which started a week after completion of phase I, patients received a course of cytotoxic chemotherapy, then a course of GM-CSF. Phase III consisted only of cytotoxic chemotherapy. GM-CSF (phase I) alone produced an 18-fold increase in peripheral blood granulocyte-macrophage colony-forming units (CFU-GM) and an 8-fold increase in erythroid burst-forming units (BFU-E) in the peripheral blood. GM-CSF had no effect on bone-marrow CFU-GM and BFU-E in the group as a whole. Three patients were investigated after phases II and III. GM-CSF increased the absolute number of peripheral blood CFU-GM by approximately 60-fold compared with the pretreatment baseline. These effects of GM-CSF may be of clinical importance with regard to facilitating the harvest of peripheral blood progenitor cells for autotransplantation.
Similar articles
-
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346. Ann Hematol. 1993. PMID: 7506580 Clinical Trial.
-
Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.Exp Hematol. 1990 Feb;18(2):94-8. Exp Hematol. 1990. PMID: 1968009
-
Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.Exp Hematol. 1989 Feb;17(2):191-7. Exp Hematol. 1989. PMID: 2463933
-
Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness.Rev Infect Dis. 1990 Jan-Feb;12(1):41-62. doi: 10.1093/clinids/12.1.41. Rev Infect Dis. 1990. PMID: 2405468 Review.
-
Mechanism of GM-CSF stimulation of neutrophils.Immunol Res. 1989;8(3):236-48. doi: 10.1007/BF02918148. Immunol Res. 1989. PMID: 2664037 Review. No abstract available.
Cited by
-
Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.Jpn J Cancer Res. 1989 Jun;80(6):577-82. doi: 10.1111/j.1349-7006.1989.tb01678.x. Jpn J Cancer Res. 1989. PMID: 2474526 Free PMC article.
-
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor.Ann Hematol. 1993 Apr;66(4):185-93. doi: 10.1007/BF01703234. Ann Hematol. 1993. PMID: 8387346 Clinical Trial.
-
Haemopoietic growth factors in paediatric oncology: a review of the literature.Paediatr Drugs. 2001;3(3):195-217. doi: 10.2165/00128072-200103030-00003. Paediatr Drugs. 2001. PMID: 11310717 Review.
-
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).Support Care Cancer. 2022 Sep;30(9):7067-7077. doi: 10.1007/s00520-022-07103-5. Support Care Cancer. 2022. PMID: 35739328 Free PMC article. No abstract available.
-
Current clinical indications for plerixafor.Transfus Med Hemother. 2013 Aug;40(4):246-50. doi: 10.1159/000354229. Epub 2013 Jul 19. Transfus Med Hemother. 2013. PMID: 24415962 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
